Hemostasis Today

July, 2026
July 2026
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Manabu Inoue: Tenecteplase or Alteplase Before Thrombectomy by T-FLAVOR Trial
Jul 24, 2026, 03:44

Manabu Inoue: Tenecteplase or Alteplase Before Thrombectomy by T-FLAVOR Trial

Manabu Inoue, Chief Medical Officer at Pharmaceuticals and Medical Devices Agency (PMDA), shared on LinkedIn about a recent article he and his colleagues co-authored, published in JAMA Neurology, adding:

”I am pleased to share that the T-FLAVOR trial has been published in JAMA Neurology.

T-FLAVOR is a multicenter, randomized clinical trial comparing tenecteplase with the approved Japanese low-dose alteplase (0.6 mg/kg) before endovascular thrombectomy in patients with acute ischemic stroke.

To our knowledge, this is the first randomized trial to evaluate these two thrombolytic strategies in Japan.

I am sincerely grateful to all investigators, study coordinators, patients, and their families for making this study possible.

I hope these findings will contribute to improving stroke care and advancing evidence-based treatment worldwide.”

Title: Standard-Dose Tenecteplase vs Low-Dose Alteplase for Acute Ischemic Stroke From Large-Vessel Occlusion. A Randomized Clinical Trial

Authors: Manabu Inoue, Teruyuki Hirano, Mayumi Fukuda-Doi, Hiroyuki Kawano, Kenta Tanaka, Nobuyuki Sakai, Masatoshi Koga, Koji Iwasaki, Tomohide Yoshie, Naruhiko Kamogawa, Masafumi Ihara, Tsuyoshi Ohta, Masaki Chin, Naoto Kimura, Kazumi Kimura, Yohei Tateishi, Tadashi Terasaki, Taketo Hatano, Takahiro Kuwashiro, Shinichi Yoshimura, Toshihiro Ueda, Eiichiro Nagata, Yoshinari Nagakane, Shinichi Takahashi, Fumio Miyashita, Kazutaka Sonoda, Kenji Fukuda, Kanta Tanaka, Yoshiko Une, Shigetaka Kobari, Takehiko Nagao, Makoto Sasaki, Haruko Yamamoto, Kazunori Toyoda for the T-FLAVOR trial Investigators

Manabu Inoue: Tenecteplase or Alteplase Before Thrombectomy by T-FLAVOR Trial

Stay updated on all scientific advances with Hemostasis Today.